Skip to main content
Research

Publications: Dr Charlotte Lindsay

Lindsay C, Davenport R, Baksaas-Aasen K, Kolstadbråten KM, Naess PA, Curry N, Maegele M, Juffermans N et al. ( 2024 ) . Correction of Trauma-induced Coagulopathy by Goal-directed Therapy: A Secondary Analysis of the ITACTIC Trial . Anesthesiology vol. 141 , ( 5 ) 904 - 912 .
Lindsay C, Green L, Henry J, O’Halloran PJ, Davenport R ( 2024 ) . Coagulopathy and Prophylaxis of Venous Thromboembolism in Traumatic Brain Injury . Traumatic Brain Injury , Springer Nature
Schofield H, Lindsay C, Brohi K, Davenport R ( 2023 ) . Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock . Journal of Thrombosis and Haemostasis vol. 22 , ( 3 ) 676 - 685 .
Hannadjas I, James A, Davenport R, Lindsay C, Brohi K, Cole E ( 2023 ) . Prothrombin complex concentrate (PCC) for treatment of trauma-induced coagulopathy: systematic review and meta-analyses . Critical Care vol. 27 , ( 1 )
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H et al. ( 2023 ) . Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet vol. 401 , ( 10387 ) 1499 - 1507 .
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H et al. ( 2022 ) . Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis . The Lancet vol. 400 , ( 10349 ) 359 - 368 .
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al. ( 2022 ) . Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet vol. 399 , ( 10325 ) 665 - 676 .
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al. ( 2021 ) . Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet vol. 399 , ( 10320 ) 143 - 151 .
Group RC ( 2021 ) . Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet Respiratory Medicine vol. 9 , ( 12 ) 1419 - 1426 .
Cottey L, Roberts T, Graham B, Horner D, Latour JM, Enki D, Lyttle MD, Stevens KN ( 2021 ) . Need for recovery and physician well-being in emergency departments: national survey findings . European Journal of Emergency Medicine vol. 28 , ( 5 ) 386 - 393 .
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al. ( 2021 ) . Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial . The Lancet vol. 397 , ( 10289 ) 2049 - 2059 .
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al. ( 2021 ) . Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial . The Lancet vol. 397 , ( 10285 ) 1637 - 1645 .
Cottey L, Roberts T, Graham B, Horner D, Stevens KN, Enki D, Lyttle MD, Latour J et al. ( 2020 ) . Need for recovery amongst emergency physicians in the UK and Ireland: a cross-sectional survey . BMJ Open vol. 10 , ( 11 )